Skip to main content

Table 7 hPL manufacturing

From: Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review

hPL manufacturing N %
Industrial (I) 9 16.07
Buffy coat (BC) 9 16.07
Platelet-rich plasma (PRP) 15 26.79
Apheresis (Aph) 11 19.64
Apheresis and/or Buffy Coat 2 3.57
Not mentioned (N.M.) 10 17.86